377 related articles for article (PubMed ID: 8895983)
1. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
Stern MC; Conti CJ
Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
[No Abstract] [Full Text] [Related]
2. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
Stern MC; Benavides F; LaCava M; Conti CJ
Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
5. Two-stage tumor promotion in mouse skin: an alternative interpretation.
Hennings H; Yuspa SH
J Natl Cancer Inst; 1985 Apr; 74(4):735-40. PubMed ID: 3921746
[No Abstract] [Full Text] [Related]
6. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
9. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
Stern MC; Benavides F; Klingelberger EA; Conti CJ
Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006
[TBL] [Abstract][Full Text] [Related]
10. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression during tumor promotion and progression in the mouse skin model.
Bowden GT; Ostrowski LE; Bonham K; Krieg P
Basic Life Sci; 1991; 57():127-40; discussion 140-1. PubMed ID: 1667569
[No Abstract] [Full Text] [Related]
12. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH
Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of multistage hepatocarcinogenesis.
Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
[No Abstract] [Full Text] [Related]
14. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
15. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
Hennings H
Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH
Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187
[TBL] [Abstract][Full Text] [Related]
17. [p53 gene mutations in mouse skin tumors induced by DMBA-TPA-MNNG].
Zhang S; Guo ; Klein-Szanto A
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):298-300. PubMed ID: 11245002
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to two-stage carcinogenesis of SENCAR mouse skin grafted to nude mice.
Yuspa SH; Spangler EF; Donahoe R; Geusz S; Ferguson E; Wenk M; Hennings H
Cancer Res; 1982 Feb; 42(2):437-9. PubMed ID: 6799187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
